# HEALSea Nasal Spray for Prevention of Infections in Children

> **NCT06582589** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lallemand Pharma AG** · enrollment: 139 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DEVICE:** Healsea Children

## Key facts

- **NCT ID:** NCT06582589
- **Lead sponsor:** Lallemand Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-25
- **Primary completion:** 2025-04-23
- **Final completion:** 2025-04-23
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582589, "HEALSea Nasal Spray for Prevention of Infections in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06582589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*